DAB2

DAB adaptor protein 2

Basic information

Region (hg38): 5:39371675-39462300

Links

ENSG00000153071NCBI:1601OMIM:601236HGNC:2662Uniprot:P98082AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the DAB2 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the DAB2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
4
clinvar
3
clinvar
7
missense
40
clinvar
3
clinvar
4
clinvar
47
nonsense
1
clinvar
1
start loss
0
frameshift
1
clinvar
1
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
1
clinvar
1
Total 0 0 42 7 8

Variants in DAB2

This is a list of pathogenic ClinVar variants found in the DAB2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
5-39375041-G-A not specified Uncertain significance (Jul 17, 2023)2602946
5-39375046-C-T Likely benign (May 16, 2018)737773
5-39375054-T-A not specified Uncertain significance (Dec 28, 2022)2340478
5-39375999-A-G not specified Uncertain significance (Jan 19, 2024)3079891
5-39376674-T-G not specified Uncertain significance (May 20, 2024)3270772
5-39376757-C-G not specified Uncertain significance (Aug 02, 2023)2615445
5-39376782-G-C not specified Uncertain significance (Apr 05, 2023)2533529
5-39376785-C-T not specified Uncertain significance (Jul 20, 2021)2370531
5-39376790-A-C not specified Uncertain significance (Jul 13, 2022)2362603
5-39376839-C-A not specified Uncertain significance (Dec 22, 2023)3079890
5-39376891-G-C not specified Uncertain significance (Jan 19, 2024)3079889
5-39376951-G-C not specified Uncertain significance (Sep 17, 2021)3079888
5-39376973-G-T not specified Uncertain significance (Jun 06, 2023)2517720
5-39377017-C-A not specified Uncertain significance (Jan 08, 2024)3079887
5-39377028-T-C Benign (Dec 31, 2019)712448
5-39377058-C-T not specified Uncertain significance (Aug 02, 2021)2240429
5-39377157-C-T Benign (Jul 26, 2018)719334
5-39377172-C-T not specified Uncertain significance (Dec 13, 2022)2334239
5-39377200-C-T Likely benign (May 14, 2018)737879
5-39377201-G-A not specified Uncertain significance (Feb 17, 2024)3079886
5-39377204-G-A not specified Likely benign (Oct 03, 2022)2407271
5-39377218-C-G Likely benign (May 18, 2018)737217
5-39377273-G-A Benign (Dec 31, 2019)782450
5-39381475-C-T not specified Uncertain significance (Jun 24, 2022)2262760
5-39381538-C-G not specified Uncertain significance (Jun 16, 2024)3270775

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
DAB2protein_codingprotein_codingENST00000320816 1390623
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.4070.5931257260101257360.0000398
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.2033974090.9720.00002115047
Missense in Polyphen93111.960.830661477
Synonymous-0.9961721561.100.000009221548
Loss of Function4.04731.40.2230.00000141383

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00009040.0000904
Ashkenazi Jewish0.000.00
East Asian0.0001630.000163
Finnish0.00004620.0000462
European (Non-Finnish)0.00002680.0000264
Middle Eastern0.0001630.000163
South Asian0.00003270.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Adapter protein that functions as clathrin-associated sorting protein (CLASP) required for clathrin-mediated endocytosis of selected cargo proteins. Can bind and assemble clathrin, and binds simultaneously to phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) and cargos containing non-phosphorylated NPXY internalization motifs, such as the LDL receptor, to recruit them to clathrin-coated pits. Can function in clathrin-mediated endocytosis independently of the AP-2 complex. Involved in endocytosis of integrin beta-1; this function seems to redundant with the AP-2 complex and seems to require DAB2 binding to endocytosis accessory EH domain-containing proteins such as EPS15, EPS15L1 and ITSN1. Involved in endocytosis of cystic fibrosis transmembrane conductance regulator/CFTR. Involved in endocytosis of megalin/LRP2 lipoprotein receptor during embryonal development. Required for recycling of the TGF-beta receptor. Involved in CFTR trafficking to the late endosome. Involved in several receptor- mediated signaling pathways. Involved in TGF-beta receptor signaling and facilitates phosphorylation of the signal transducer SMAD2. Mediates TFG-beta-stimulated JNK activation. May inhibit the canoniocal Wnt/beta-catenin signaling pathway by stabilizing the beta-catenin destruction complex through a competing association with axin preventing its dephosphorylation through protein phosphatase 1 (PP1). Sequesters LRP6 towards clathrin- mediated endocytosis, leading to inhibition of Wnt/beta-catenin signaling. May activate non-canonical Wnt signaling. In cell surface growth factor/Ras signaling pathways proposed to inhibit ERK activation by interrupting the binding of GRB2 to SOS1 and to inhibit SRC by preventing its activating phosphorylation at 'Tyr- 419'. Proposed to be involved in modulation of androgen receptor (AR) signaling mediated by SRC activation; seems to compete with AR for interaction with SRC. Plays a role in the CSF-1 signal transduction pathway. Plays a role in cellular differentiation. Involved in cell positioning and formation of visceral endoderm (VE) during embryogenesis and proposed to be required in the VE to respond to Nodal signaling coming from the epiblast. Required for the epithelial to mesenchymal transition, a process necessary for proper embryonic development. May be involved in myeloid cell differentiation and can induce macrophage adhesion and spreading. May act as a tumor suppressor. {ECO:0000269|PubMed:11387212, ECO:0000269|PubMed:12805222, ECO:0000269|PubMed:16267015, ECO:0000269|PubMed:16984970, ECO:0000269|PubMed:19306879, ECO:0000269|PubMed:21995445, ECO:0000269|PubMed:22323290, ECO:0000269|PubMed:22491013}.;
Pathway
Endocytosis - Homo sapiens (human);WNT-Ncore;TGF-Ncore;Endoderm Differentiation;TGF-beta Signaling Pathway;Vesicle-mediated transport;Membrane Trafficking;Clathrin-mediated endocytosis;TGF_beta_Receptor;EGFR1;Cargo recognition for clathrin-mediated endocytosis;Formation of annular gap junctions;Gap junction degradation;Gap junction trafficking;Gap junction trafficking and regulation;TGF-beta receptor signaling (Consensus)

Recessive Scores

pRec
0.319

Intolerance Scores

loftool
0.134
rvis_EVS
1.05
rvis_percentile_EVS
91.34

Haploinsufficiency Scores

pHI
0.327
hipred
Y
hipred_score
0.786
ghis
0.443

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.998

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Dab2
Phenotype
mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; renal/urinary system phenotype; growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype;

Zebrafish Information Network

Gene name
dab2
Affected structure
post-vent vasculature
Phenotype tag
abnormal
Phenotype quality
decreased process quality

Gene ontology

Biological process
positive regulation of protein phosphorylation;receptor-mediated endocytosis;apoptotic process;integrin-mediated signaling pathway;multicellular organism development;cell population proliferation;positive regulation of epithelial to mesenchymal transition;positive regulation of pathway-restricted SMAD protein phosphorylation;protein transport;Wnt signaling pathway;positive regulation of cell migration;positive regulation of transforming growth factor beta receptor signaling pathway;negative regulation of protein binding;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;leading edge cell differentiation;negative regulation of apoptotic process;positive regulation of endocytosis;negative regulation of transcription, DNA-templated;positive regulation of transcription, DNA-templated;positive regulation of SMAD protein signal transduction;negative regulation of androgen receptor signaling pathway;membrane organization;negative regulation of canonical Wnt signaling pathway;negative regulation of protein localization to plasma membrane;positive regulation of Wnt signaling pathway, planar cell polarity pathway;positive regulation of clathrin-dependent endocytosis;positive regulation of early endosome to late endosome transport
Cellular component
fibrillar center;lysosomal membrane;cytosol;plasma membrane;clathrin-coated pit;focal adhesion;clathrin-coated vesicle;clathrin-coated vesicle membrane;intracellular membrane-bounded organelle
Molecular function
protein binding;protein C-terminus binding;clathrin adaptor activity;cargo receptor activity;SMAD binding